2016 VAM: 1008 - Pathogenesis of Chronic Rhinosinusitis

AMA PRA Category 1 Credits™: 2.50 
CE: 2.50

Credit must be claimed by May 31, 2018.  Any credit request on or after June 1, 2018 will be subject to an administrative fee.

Target Audience

Physicians
Allergists/Immunologists
Nurses
Nurse Practitioners
Allied Health Professionals

Learning Objectives

Upon completion of this session, participants should be able to:

1.  Discuss the role of TSLP and its metabolic products in the inflammation of nasal polyps
2.  Recognize the mechanisms by which IL-33 contributes to the pathogenesis of CRS with nasal polyps and the potential to target this cytokine in therapy
3.  Identify the mechanisms by which PGD2 directs inflammation in rhinosinusitis and nasal polyps and become aware of unique aspects of the pathology and pathophysiology of nasal polyp disease in Asia and in Europe

Additional Information

AttachmentSize
2016 Annual Meeting Disclosures120.13 KB
Summary
Available credit: 
  • 2.50 Attendance
    Attendance credit.
  • 2.50 CE
    CE credit.
  • 2.50 CME
    CME credit.
Course opens: 
05/31/2016
Course expires: 
05/31/2018
Cost:
$15.00
Rating: 
0

Claus Bachert, MD PhD, Universitair Ziekenhuis Gent, Ghent, Belgium

Joshua A. Boyce, MD FAAAAI, Brigham and Women's Hospital, Boston, MA

Katherine N. Cahill, MD, Harvard Medical School, Boston, MA

Atsushi Kato, PhD, Northwestern University Feinberg School of Medicine, Chicago, IL

Marek L. Kowalski, MD PhD, Medical University of Lodz, Lodz, Poland 

Available Credit

  • 2.50 Attendance
    Attendance credit.
  • 2.50 CE
    CE credit.
  • 2.50 CME
    CME credit.

Accreditation Period

Course opens: 
05/31/2016
Course expires: 
05/31/2018

Price

Cost:
$15.00
Please login or register to take this course.

Required Hardware/software

Our system supports the two most recent versions of Safari, Google Chrome, and Firefox. Internet Explorer is not recommended.